3.79 Is the IRB responsible? An institutional review board (IRB) approved an experimental cancer vaccine for use in a clinical trial. The subjects were patients who had advanced disease and had received standard treatments with no success. Of the 94 subjects who received the vaccine, 26 died during the study. Their deaths were not due to the vaccine. Some family members of the subjects sued the hospital, the study director, the company that made the vaccine, a university official, individual members of the IRB, and the university bioethicist who consulted with the IRB.³¹ Discuss this case from the point of view of ethics. Include any additional information that you would need to form your opinion.